Form 4: Labcorp Director Wengel Receives RSU Grant
Insider Transaction Report
Labcorp Holdings Inc. Director Kathryn E. Wengel reported the acquisition of 773 Restricted Stock Units, vesting in 2027.
Summary
- Kathryn E. Wengel, a Director of Labcorp Holdings Inc. (LH), acquired 773 Restricted Stock Units (RSUs).
- The transaction date for this acquisition was February 10, 2026.
- Each RSU represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- These 773 RSUs will vest fully on February 10, 2027.
- Following this transaction, the aggregate number of Restricted Stock Units beneficially owned by Ms. Wengel is 1,670.
- A Power of Attorney was granted by Kathryn E. Wengel to Kathryn W. Kyle on December 9, 2025, for Section 16 filings.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard director compensation practices and aligning the director's interests with the company's long-term performance through equity ownership.
Positives
- The grant of 773 Restricted Stock Units aligns the director's interests with long-term shareholder value.
- The vesting schedule provides an incentive for continued service and performance through February 10, 2027.
Future Outlook
The vesting of the granted Restricted Stock Units on February 10, 2027, represents a future milestone for the director's equity compensation.
Industry Context
StockSavvy.ai notes that equity grants, such as Restricted Stock Units, are a common component of executive and director compensation packages across various industries, including healthcare and diagnostics, to align leadership incentives with long-term company performance and shareholder interests.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Kathryn E. Wengel granted a Power of Attorney to Kathryn W. Kyle to execute and file Forms 3, 4, and 5 on her behalf, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934. | 2025-12-09 | Enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions. |
Related Party Transactions
- The acquisition of 773 Restricted Stock Units by Director Kathryn E. Wengel from Labcorp Holdings Inc. is a transaction between a company and its director, which is considered a related party transaction.
Stakeholder Impact
- Shareholders: The grant of RSUs may result in minor dilution upon vesting, but aims to align director incentives with long-term shareholder value.
- Director (Kathryn E. Wengel): Receives additional equity compensation, increasing her stake and aligning her financial interests with the company's performance.
Next Steps
- The 773 Restricted Stock Units are scheduled to vest fully on February 10, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-12-09 | Kathryn E. Wengel signed a Power of Attorney appointing Kathryn W. Kyle as attorney-in-fact for Section 16 filings. |
| 2026-02-10 | Date of acquisition of 773 Restricted Stock Units by Kathryn E. Wengel. |
| 2026-02-12 | Date the Form 4 was signed by the attorney-in-fact. |
| 2027-02-10 | Date when the 773 Restricted Stock Units will fully vest. |
Keywords
Labcorp Holdings Inc., LH, Kathryn E. Wengel, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, SEC Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.